Registered number
13995495
Nationwide Cardiovascular Limited
Filleted Accounts
31 March 2025
Nationwide Cardiovascular Limited
Registered number: 13995495
Balance Sheet
as at 31 March 2025
Notes 2025 2024
£ £
Fixed assets
Tangible assets 4 1,198 360
Investments 5 36,365 24,802
37,563 25,162
Current assets
Debtors 6 4,584 7,168
Cash at bank and in hand 123,456 42,175
128,040 49,343
Creditors: amounts falling due within one year 7 (44,925) (19,617)
Net current assets 83,115 29,726
Total assets less current liabilities 120,678 54,888
Creditors: amounts falling due after more than one year 8 (11,111) -
Provisions for liabilities (299) -
Net assets 109,268 54,888
Capital and reserves
Called up share capital 10 10
Profit and loss account 109,258 54,878
Shareholders' funds 109,268 54,888
The directors are satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The members have not required the company to obtain an audit in accordance with section 476 of the Act.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.
Dr Charis Costopulos
Director
Approved by the board on 18 July 2025
Nationwide Cardiovascular Limited
Notes to the Accounts
for the year ended 31 March 2025
1 Accounting policies
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Going concern
The financial statements have been prepared on a going concern basis.

The directors have made an assessment in preparing these financial statements as to whether the Company is a going concern and have concluded that there are no material uncertainties that may cast significant doubt on the Company’s ability to continue as a going concern for the period of at least 12 months from the date of approval of these financial statements.
Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the rendering of services. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Tangible fixed assets
Tangible fixed assets are measured at cost less accumulative depreciation and any accumulative impairment losses. Depreciation is provided on all tangible fixed assets, other than freehold land, at rates calculated to write off the cost, less estimated residual value, of each asset evenly over its expected useful life, as follows:
Freehold buildings over 50 years
Leasehold land and buildings over the lease term
Plant and machinery over 5 years
Fixtures, fittings, tools and equipment over 2 years
Investments
Investments in subsidiaries, associates and joint ventures are measured at cost less any accumulated impairment losses. Listed investments are measured at fair value. Unlisted investments are measured at fair value unless the value cannot be measured reliably, in which case they are measured at cost less any accumulated impairment losses. Changes in fair value are included in the profit and loss account.
Stocks
Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first in first out method. The carrying amount of stock sold is recognised as an expense in the period in which the related revenue is recognised.
Debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
Taxation
A current tax liability is recognised for the tax payable on the taxable profit of the current and past periods. A current tax asset is recognised in respect of a tax loss that can be carried back to recover tax paid in a previous period. Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Pensions
Contributions to defined contribution plans are expensed in the period to which they relate.
2 Employees 2025 2024
Number Number
Average number of persons employed by the company 1 1
3 Taxation 2025 2024
£ £
Current year corporation tax charge 26,189 11,330
Deferred Tax on timing differences 299 -
26,488 11,330
4 Tangible fixed assets
Plant and machinery etc
£
Cost
At 1 April 2024 1,233
Additions 1,625
At 31 March 2025 2,858
Depreciation
At 1 April 2024 873
Charge for the year 787
At 31 March 2025 1,660
Net book value
At 31 March 2025 1,198
At 31 March 2024 360
5 Investments
Investments in
subsidiary Other
undertakings investments Total
£ £ £
Cost
At 1 April 2024 - 24,802 24,802
Additions 3,000 - 3,000
Revaluation - 8,563 8,563
At 31 March 2025 3,000 33,365 36,365
6 Debtors 2025 2024
£ £
Other debtors 4,584 7,168
7 Creditors: amounts falling due within one year 2025 2024
£ £
Bank loans and overdrafts 6,667 -
Taxation and social security costs 26,189 11,764
Other creditors 12,069 7,853
44,925 19,617
8 Creditors: amounts falling due after one year 2025 2024
£ £
Bank loans 11,111 -
9 Other information
Nationwide Cardiovascular Limited is a private company limited by shares and incorporated in England. Its registered office is:
Suite 3a Kings Hall
St Ives Business Park, Parsons Green
St Ives
Cambridgeshire
PE27 4WY
Nationwide Cardiovascular Limited 13995495 false 2024-04-01 2025-03-31 2025-03-31 VT Final Accounts April 2024 Dr Charis Costopulos No description of principal activity 13995495 2023-04-01 2024-03-31 13995495 core:WithinOneYear 2024-03-31 13995495 core:AfterOneYear 2024-03-31 13995495 core:ShareCapital 2024-03-31 13995495 core:RetainedEarningsAccumulatedLosses 2024-03-31 13995495 2024-04-01 2025-03-31 13995495 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 13995495 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 13995495 bus:Director40 2024-04-01 2025-03-31 13995495 1 2024-04-01 2025-03-31 13995495 2 2024-04-01 2025-03-31 13995495 core:PlantMachinery 2024-04-01 2025-03-31 13995495 countries:England 2024-04-01 2025-03-31 13995495 bus:FRS102 2024-04-01 2025-03-31 13995495 bus:FilletedAccounts 2024-04-01 2025-03-31 13995495 2025-03-31 13995495 core:WithinOneYear 2025-03-31 13995495 core:AfterOneYear 2025-03-31 13995495 core:ShareCapital 2025-03-31 13995495 core:RetainedEarningsAccumulatedLosses 2025-03-31 13995495 core:PlantMachinery 2025-03-31 13995495 core:AdditionsToInvestments 2025-03-31 13995495 core:RevaluationsIncreaseDecreaseInInvestments 2025-03-31 13995495 2024-03-31 13995495 core:PlantMachinery 2024-03-31 iso4217:GBP xbrli:pure